Charlie Silver is the Founding CEO and Co-Founder of Ruby Bio, a biosynthesis company on a mission to decarbonize the $1T petrochemicals industry by replacing harmful chemicals with biodegradable, non-toxic alternatives.

Charlie holds an MBA from UC Berkeley's Haas School of Business and a BA in Physics from Columbia University, and previously held engineering and business development roles at Agilent Technologies and Lawrence Berkeley National Labs.

A serial entrepreneur with deep expertise spanning biotech, engineering, and sustainability, Charlie is driven by the conviction that the private sector can lead the global shift away from petrochemicals.

Before Ruby Bio, Charlie co-founded Mission Bio, a single-cell multi-omics company, where he scaled the business globally and helped raise over $120M for commercialization and growth.

Ruby Bio has raised $13.1M across two funding rounds and was selected for the Mondelez International CoLab Tech 2026 program, validating its yeast-based platform as a leading sustainable chemistry solution.